SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GUMM - Eliminate the Common Cold
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: DanZ who wrote (4864)11/6/2003 11:24:25 PM
From: StockDung   of 5582
 
One correspondent pointed me to a document (The Middle-Class Plague: Epidemic Polio and the Canadian State, 1936-1937) healthheritageresearch.com that mentions anosmia as a side effect of intranasal application of zinc sulfate in humans. It seems that Canadian researchers, back in the 1930's, experimented with the intranasal application of zinc sulfate as a prophylactic intended to prevent the polio virus from entering the brain through the olfactory neurons. The researchers expected the zinc solution to produce temporary anosmia, and not more than a quarter of the treated children reported having lost their sense of smell. Some of these children still had not regained their sense of smell months later. Whether they ever did I just do not know. One of the researchers tried the solution on himself and he also became anosmic. I really would like to know how long the anosmia in these children lasted. If you find a reference to this, please advise me."

personal.ecu.edu
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News